These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30711764)

  • 1. Prognostic factors of disability in relapsing remitting multiple sclerosis.
    Briggs FBS; Thompson NR; Conway DS
    Mult Scler Relat Disord; 2019 May; 30():9-16. PubMed ID: 30711764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.
    Langer-Gould A; Popat RA; Huang SM; Cobb K; Fontoura P; Gould MK; Nelson LM
    Arch Neurol; 2006 Dec; 63(12):1686-91. PubMed ID: 17172607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
    Voloshyna N; Havrdová E; Hutchinson M; Nehrych T; You X; Belachew S; Hotermans C; Paes D
    Eur J Neurol; 2015 Mar; 22(3):570-7. PubMed ID: 25511792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability and prognosis of relapsing remitting multiple sclerosis, is it different in Iraqi patients?
    Hasan ZN
    Neurosciences (Riyadh); 2011 Jul; 16(3):233-6. PubMed ID: 21677613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.
    Achiron A; Barak Y; Rotstein Z
    Mult Scler; 2003 Oct; 9(5):486-91. PubMed ID: 14582775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis.
    Binquet C; Quantin C; Le Teuff G; Pagliano JF; Abrahamowicz M; Moreau T
    Neuroepidemiology; 2006; 27(1):45-54. PubMed ID: 16825794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
    Feys P; Bibby BM; Baert I; Dalgas U
    Eur J Phys Rehabil Med; 2015 Apr; 51(2):207-10. PubMed ID: 25180640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
    Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating patient-reported outcomes and quantitative timed tasks to identify relapsing remitting multiple sclerosis patient subgroups: a latent profile analysis.
    Briggs FBS; Conway DS; De Nadai AS; Ontaneda D; Gunzler DD
    Mult Scler Relat Disord; 2021 Jun; 51():102912. PubMed ID: 33773274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
    Shirani A; Zhao Y; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Gustafson P; Petkau J; Tremlett H
    JAMA; 2012 Jul; 308(3):247-56. PubMed ID: 22797642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor unit discharge characteristics and walking performance of individuals with multiple sclerosis.
    Almuklass AM; Davis L; Hamilton LD; Vieira TM; Botter A; Enoka RM
    J Neurophysiol; 2018 Apr; 119(4):1273-1282. PubMed ID: 29357453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessment of hand function in individuals with multiple sclerosis.
    Newsome SD; von Geldern G; Shou H; Baynes M; Marasigan RER; Calabresi PA; Zackowski KM
    Mult Scler Relat Disord; 2019 Jul; 32():107-113. PubMed ID: 31085489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
    Wolkorte R; Heersema DJ; Zijdewind I
    Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
    Ensari I; Motl RW; McAuley E; Mullen SP; Feinstein A
    Mult Scler; 2014 Apr; 20(5):602-9. PubMed ID: 24067897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis.
    Motl RW; Weikert M; Suh Y; Sosnoff JJ; Pula J; Soaz C; Schimpl M; Lederer C; Daumer M
    Gait Posture; 2012 Feb; 35(2):192-6. PubMed ID: 21945386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients.
    Bove R; Healy BC; Musallam A; Soltany P; Diaz-Cruz C; Sattarnezhad N; Glanz BI; Kivisäkk P; Miller KK; Chitnis T
    Mult Scler; 2019 Mar; 25(3):344-351. PubMed ID: 29320952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.